Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy

  • J. Whang-Peng
  • , D. E. Lees
  • , W. H. Schuette
  • , R. Smith
  • , J. M. Bull
  • , V. T. DeVita

Research output: Contribution to journalArticlepeer-review

Abstract

The osmotic fragility of erythrocytes was studied in 24 patients receiving whole-body hyperthermia, with and without concomitant chemotherapy, for 2-4 hours as an adjuvant to chemotherapy for advanced metastatic disease. No alteration in osmotic fragility of erythrocytes was observed with whole-body hyperthermia.

Original languageEnglish
Pages (from-to)1103-1104
Number of pages2
JournalCancer Treatment Reports
Volume65
Issue number11-12
Publication statusPublished - Dec 1 1981
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy'. Together they form a unique fingerprint.

Cite this